• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

it was the best of times it was the worst of times

Anonymous

Guest
What is happening in the US economy now is a hollowing out of the traditional consumer class. Permanent downshifting. Why is this relevant for pharma? Very simple, glad you asked! As we transition to lower incomes, big fat greasy pieces of meat end up in the oven, on the griddle, or in the grill less often.

Obesity declines, insulin demand plummets. Bad economies are good for health (outside of a big spike in suicide recently for men only).

Be sure to keep six months worth of income in the bank, it's getting worse, not better.

We keep pumping out those me-too drugs, what a marvel of FIPNET and clueless contractors running around fulfilling their 20 metrics daily.